Putnam Biorevolution Etf One Year Return
| SYNB Etf | USD 30.52 0.23 0.76% |
Putnam Biorevolution ETF fundamentals help investors to digest information that contributes to Putnam Biorevolution's financial success or failures. It also enables traders to predict the movement of Putnam Etf. The fundamental analysis module provides a way to measure Putnam Biorevolution's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Putnam Biorevolution etf.
Putnam |
Putnam Biorevolution ETF ETF One Year Return Analysis
Putnam Biorevolution's One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
More About One Year Return | All Equity Analysis
One Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Current Putnam Biorevolution One Year Return | 13.90 % |
Most of Putnam Biorevolution's fundamental indicators, such as One Year Return, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Putnam Biorevolution ETF is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
| Competition |
Based on the recorded statements, Putnam Biorevolution ETF has an One Year Return of 13.9%. This is much higher than that of the Putnam family and significantly higher than that of the Health category. The one year return for all United States etfs is notably lower than that of the firm.
Putnam One Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Putnam Biorevolution's direct or indirect competition against its One Year Return to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Putnam Biorevolution could also be used in its relative valuation, which is a method of valuing Putnam Biorevolution by comparing valuation metrics of similar companies.Putnam Biorevolution is currently under evaluation in one year return as compared to similar ETFs.
Fund Asset Allocation for Putnam Biorevolution
The fund consists of 95.73% investments in stocks, with the rest of investments allocated between various types of exotic instruments.Asset allocation divides Putnam Biorevolution's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Putnam Fundamentals
| One Year Return | 13.90 % | |||
| Equity Positions Weight | 95.73 % |
About Putnam Biorevolution Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Putnam Biorevolution ETF's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Putnam Biorevolution using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Putnam Biorevolution ETF based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Putnam Biorevolution ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Putnam Biorevolution's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Putnam Biorevolution Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Putnam Biorevolution Etf:Check out Putnam Biorevolution Piotroski F Score and Putnam Biorevolution Altman Z Score analysis. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
The market value of Putnam Biorevolution ETF is measured differently than its book value, which is the value of Putnam that is recorded on the company's balance sheet. Investors also form their own opinion of Putnam Biorevolution's value that differs from its market value or its book value, called intrinsic value, which is Putnam Biorevolution's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Putnam Biorevolution's market value can be influenced by many factors that don't directly affect Putnam Biorevolution's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Putnam Biorevolution's value and its price as these two are different measures arrived at by different means. Investors typically determine if Putnam Biorevolution is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Putnam Biorevolution's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.